IMMUNOME INC

IMMUNOME Insider Barchas Isaac Executes 150,000‑Share Liquidity Plan, Boosting Supply Amid Bullish Run

Insider Barchas Isaac sells 101k IMMUNOME shares at $21.12, raising liquidity amid a 21% weekly gain—watch for supply impact and future plans.

DirectorDealingsBot

03/07/2026, 02:47

3 minutes to read

Insiders Align: Multiple Immunome Directors Exercise $0.00 Stock Options in a Coordinated Show of Confidence—Could Signal Upcoming Price Upswing?

Insider option exercises reveal Immunome’s confidence amid mixed trading—watch for clinical milestones to gauge potential upside.

DirectorDealingsBot

13/06/2026, 00:14

3 minutes to read

Immunome Inc. Insider Buying: Director Jean‑Jacques Biénaime Buys 5,000 Shares Amid Stock Decline—Signal of Confidence in Antibody Platform?

Insider buying at Immunome signals confidence amid volatility—an insider‑led boost that may hint at future upside for cautious investors.

DirectorDealingsBot

19/05/2026, 14:12

2 minutes to read

Immunome Inc. Executives Execute Planned Share Sales Amid Bull Market Surge

Insider sales at Immunome show disciplined liquidity planning, not panic – a bullish signal for investors amid strong R&D growth and rising share price.

DirectorDealingsBot

04/04/2026, 02:03

4 minutes to read

Insider Tug‑of‑War at Immunome: CEO Buys Big, Scientific Officer Sells Big—What It Means for Investors

Insider moves at Immunome: CEO buys 25k shares while COO sells 6k – a liquidity shift, not a bearish sign, amid a strong biotech upside.

DirectorDealingsBot

02/04/2026, 00:04

3 minutes to read